Journey Medical Valuation
| DERM Stock | USD 8.36 0.09 1.07% |
At this time, the firm appears to be overvalued. Journey Medical Corp retains a regular Real Value of $6.99 per share. The prevalent price of the firm is $8.36. Our model calculates the value of Journey Medical Corp from evaluating the firm fundamentals such as Current Valuation of 281.37 M, return on asset of -0.046, and Return On Equity of -0.47 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Journey Medical's valuation include:
Price Book 10.7354 | Enterprise Value | Enterprise Value Ebitda 17.7192 | Price Sales 4.731 | Forward PE 34.8432 |
Overvalued
Today
Please note that Journey Medical's price fluctuation is slightly risky at this time. Calculation of the real value of Journey Medical Corp is based on 3 months time horizon. Increasing Journey Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Journey stock is determined by what a typical buyer is willing to pay for full or partial control of Journey Medical Corp. Since Journey Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Journey Stock. However, Journey Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.36 | Real 6.99 | Target 13.5 | Hype 8.45 | Naive 8.78 |
The intrinsic value of Journey Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Journey Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Journey Medical Corp helps investors to forecast how Journey stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Journey Medical more accurately as focusing exclusively on Journey Medical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Journey Medical's intrinsic value based on its ongoing forecasts of Journey Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Journey Medical's closest peers.
Journey Medical Cash |
|
Journey Revenue by Product
Journey Medical Total Value Analysis
Journey Medical Corp is currently projected to have valuation of 281.37 M with market capitalization of 281.02 M, debt of 25.7 M, and cash on hands of 38.14 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Journey Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
281.37 M | 281.02 M | 25.7 M | 38.14 M |
Journey Medical Investor Information
About 24.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.35. Journey Medical Corp had not issued any dividends in recent years. Journey Medical Corp is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.Journey Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Journey Medical has an asset utilization ratio of 69.96 percent. This suggests that the Company is making $0.7 for each dollar of assets. An increasing asset utilization means that Journey Medical Corp is more efficient with each dollar of assets it utilizes for everyday operations.Journey Medical Profitability Analysis
Taking into consideration Journey Medical's profitability measurements, Journey Medical Corp may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Journey Medical's ability to earn profits and add value for shareholders.Net Loss | First Reported 2014-12-31 | Previous Quarter -3.8 M | Current Value -2.3 M | Quarterly Volatility 34 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.74 | 0.72 |
|
|
For Journey Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Journey Medical Corp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Journey Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Journey Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Journey Medical over time as well as its relative position and ranking within its peers.
Journey Medical Earnings per Share Projection vs Actual
The next projected EPS of Journey Medical is estimated to be 0.063125 with future projections ranging from a low of 0.0425 to a high of 0.09. Journey Medical's most recent 12-month trailing earnings per share (EPS TTM) is at -0.35. Please be aware that the consensus of earnings estimates for Journey Medical Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.Journey Medical Earnings Estimation Breakdown
The calculation of Journey Medical's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Journey Medical is estimated to be 0.063125 with the future projection ranging from a low of 0.0425 to a high of 0.09. Please be aware that this consensus of annual earnings estimates for Journey Medical Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.04 Lowest | Expected EPS | 0.09 Highest |
Journey Medical Earnings Projection Consensus
Suppose the current estimates of Journey Medical's value are higher than the current market price of the Journey Medical stock. In this case, investors may conclude that Journey Medical is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Journey Medical's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 4 | 55.39% | 0.0 | 0.063125 | -0.35 |
Journey Medical Ownership Allocation
Journey Medical Corp has a total of 27.26 Million outstanding shares. Journey Medical secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Journey Medical Profitability Analysis
The company reported the previous year's revenue of 56.13 M. Net Loss for the year was (14.67 M) with profit before overhead, payroll, taxes, and interest of 39.23 M.About Journey Medical Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Journey Medical Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Journey Medical Corp based exclusively on its fundamental and basic technical indicators. By analyzing Journey Medical's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Journey Medical's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Journey Medical. We calculate exposure to Journey Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Journey Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 40.5 M | 29.9 M | |
| Pretax Profit Margin | (0.23) | (0.25) | |
| Operating Profit Margin | (0.22) | (0.23) | |
| Net Loss | (0.24) | (0.25) | |
| Gross Profit Margin | 0.72 | 0.74 |
Journey Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Journey Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 20.4 M | |
| Forward Price Earnings | 34.8432 |
Journey Medical Current Valuation Indicators
Journey Medical's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Journey Medical's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Journey Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Journey Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Journey Medical's worth.When determining whether Journey Medical Corp is a strong investment it is important to analyze Journey Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Journey Medical's future performance. For an informed investment choice regarding Journey Stock, refer to the following important reports: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Will Biotechnology sector continue expanding? Could Journey diversify its offerings? Factors like these will boost the valuation of Journey Medical. Projected growth potential of Journey fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Journey Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.35) | Revenue Per Share | Quarterly Revenue Growth 0.205 | Return On Assets | Return On Equity |
Understanding Journey Medical Corp requires distinguishing between market price and book value, where the latter reflects Journey's accounting equity. The concept of intrinsic value—what Journey Medical's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Journey Medical's price substantially above or below its fundamental value.
It's important to distinguish between Journey Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Journey Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Journey Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.